Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"Leaky gut"

Keywords

Publication year

"Leaky gut"

Review

Liver fibrosis, cirrhosis, and portal hypertension

The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
Yeon Seok Seo, Vijay H. Shah
Korean J Hepatol 2012;18(4):337-346.
Published online December 21, 2012
DOI: https://doi.org/10.3350/cmh.2012.18.4.337

Because of the anatomical position and its unique vascular system, the liver is susceptible to the exposure to the microbial products from the gut. Although large amount of microbes colonize in the gut, translocation of the microbes or microbial products into the liver and systemic circulation is prevented by gut epithelial barrier function and cleansing and detoxifying functions of the liver in healthy subjects. However, when the intestinal barrier function is disrupted, large amount of bacterial products can enter into the liver and systemic circulation and induce inflammation through their receptors. Nowadays, there have been various reports suggesting the role of gut flora and bacterial translocation in the pathogenesis of chronic liver disease and portal hypertension. This review summarizes the current knowledge about bacterial translocation and its contribution to the pathogenesis of chronic liver diseases and portal hypertension.

Citations

Citations to this article as recorded by  Crossref logo
  • Effects of direct anti-viral agents on the gut microbiota in patients with chronic hepatitis C
    Pao-Yuan Huang, Chien-Hung Chen, Mu-Jung Tsai, Chih-Chien Yao, Hsin-Ming Wang, Yuan-Hung Kuo, Kuo-Chin Chang, Chao-Hung Hung, Seng-Kee Chuah, Ming-Chao Tsai
    Journal of the Formosan Medical Association.2022;[Epub]     CrossRef
  • Alterations in circadian rhythms aggravate Acetaminophen-induced liver injury in mice by influencing Acetaminophen metabolization and increasing intestinal permeability
    Kun Zhang, Xiude Fan, Xiaoyun Wang, Xiaoge Zhang, Lu Zeng, Na Li, Qunying Han, Yi Lv, Zhengwen Liu
    Bioengineered.2022; 13(5): 13118.     CrossRef
  • 7-O-(2- (Propylamino)-2-oxoethyl) hesperetin attenuates inflammation and protects against alcoholic liver injury by NLRP12
    Xue-ni Niu, Yi-long Zhang, Miao Cheng, Na-na Yin, Yuan-yuan Wu, Wen Shi, Ying-li Yang, Lin Zhu, Cheng Huang, Jun Li
    International Immunopharmacology.2022; 110: 109006.     CrossRef
  • Konjac oligosaccharides attenuate DSS-induced ulcerative colitis in mice: mechanistic insights
    Pengkui Xia, Tao Hou, Muyuan Ma, Sha Li, Hong Jin, Xuan Luo, Jing Li, Fang Geng, Bin Li
    Food & Function.2022; 13(10): 5626.     CrossRef
  • Inchinkoto, the Traditional Japanese Kampo Medicine, Enhances Intestinal Epithelial Barrier Function In Vitro
    Ayaka Nakao, Ailing Hu, Takuji Yamaguchi, Masahiro Tabuchi, Yasushi Ikarashi, Hiroyuki Kobayashi, Talha Bin Emran
    Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1.     CrossRef
  • New perspective on fecal microbiota transplantation in liver diseases
    Ki Tae Suk, Hong Koh
    Journal of Gastroenterology and Hepatology.2022; 37(1): 24.     CrossRef
  • Influence of Gut–Liver Axis on Portal Hypertension in Advanced Chronic Liver Disease: The Gut Microbiome as a New Protagonist in Therapeutic Management
    Francesco Santopaolo, Gaetano Coppola, Lucia Giuli, Antonio Gasbarrini, Francesca Romana Ponziani
    Microbiology Research.2022; 13(3): 539.     CrossRef
  • Food-Specific IgE and IgG Antibodies in Patients With Chronic Rhinosinusitis With Nasal Polyps: A Case–Control Study
    Rafaela Veloso-Teles, Rui Cerejeira, Débora Rodrigues, Rosa Roque-Farinha, Christian von Buchwald
    Ear, Nose & Throat Journal.2021; 100(3): 177.     CrossRef
  • Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications
    Csaba Matyas, György Haskó, Lucas Liaudet, Eszter Trojnar, Pal Pacher
    Nature Reviews Cardiology.2021; 18(2): 117.     CrossRef
  • TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapy
    Matthew M. Cousins, Emily Morris, Christopher Maurino, Theresa P. Devasia, David Karnak, Dipankar Ray, Neehar D. Parikh, Dawn Owen, Randall K. Ten Haken, Matthew J. Schipper, Theodore S. Lawrence, Kyle C. Cuneo
    Translational Oncology.2021; 14(1): 100950.     CrossRef
  • The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy
    Zefeng Chen, Jingsheng Ruan, Dinghua Li, Min Wang, Zhiwei Han, Wenxia Qiu, Guobin Wu
    Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
  • The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies
    Burcin Özdirik, Tobias Müller, Alexander Wree, Frank Tacke, Michael Sigal
    International Journal of Molecular Sciences.2021; 22(13): 6975.     CrossRef
  • Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis
    Norihisa Nishimura, Kosuke Kaji, Koh Kitagawa, Yasuhiko Sawada, Masanori Furukawa, Takahiro Ozutsumi, Yukihisa Fujinaga, Yuki Tsuji, Hiroaki Takaya, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Hiroshi Fukui, Hitoshi Yoshiji
    International Journal of Molecular Sciences.2021; 22(13): 6921.     CrossRef
  • Intestinal Barrier in Human Health and Disease
    Natalia Di Tommaso, Antonio Gasbarrini, Francesca Romana Ponziani
    International Journal of Environmental Research and Public Health.2021; 18(23): 12836.     CrossRef
  • Friend or Foe? Impacts of Dietary Xylans, Xylooligosaccharides, and Xylanases on Intestinal Health and Growth Performance of Monogastric Animals
    Jonathan T. Baker, Marcos E. Duarte, Debora M. Holanda, Sung Woo Kim
    Animals.2021; 11(3): 609.     CrossRef
  • β-blockers in advanced cirrhosis: More friend than enemy
    Ki Tae Yoon, Hongqun Liu, Samuel S. Lee
    Clinical and Molecular Hepatology.2021; 27(3): 425.     CrossRef
  • Eradication of Chronic HCV Infection: Improvement of Dysbiosis Only in Patients Without Liver Cirrhosis
    Freya Wellhöner, Nico Döscher, Franziska Woelfl, Marius Vital, Iris Plumeier, Silke Kahl, Andrej Potthoff, Michael Peter Manns, Dietmar Helmut Pieper, Markus Cornberg, Heiner Wedemeyer, Benjamin Heidrich
    Hepatology.2021; 74(1): 72.     CrossRef
  • Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update
    Hiroshi Fukui
    Gut and Liver.2021; 15(5): 666.     CrossRef
  • Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma
    Watcharin Loilome, Hasaya Dokduang, Manida Suksawat, Sureerat Padthaisong
    Expert Opinion on Investigational Drugs.2021; 30(9): 985.     CrossRef
  • Gut–Liver Axis: Liver Sinusoidal Endothelial Cells Function as the Hepatic Barrier in Colitis-Induced Liver Injury
    Yang Wang, Yifan Zhang, Yun Liu, Jun Xu, Yulan Liu
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
    Satya Priya Sharma, Ki Tae Suk, Dong Joon Kim
    World Journal of Gastroenterology.2021; 27(37): 6161.     CrossRef
  • Effect of Additional Clostridium butyricum on the Intestinal Flora of Chronic Hepatitis B Patients Treated with Entecavir
    Yu-Xia Lu, Yi-Zhong Chang, Ping Liang, Chang-Qing Yang
    Infectious Diseases and Therapy.2021; 10(3): 1519.     CrossRef
  • PTP1B promotes macrophage activation by regulating the NF-κB pathway in alcoholic liver injury
    Lei Yang, Ying-yin Sun, Ya-ru Liu, Na-na Yin, Fang-tian Bu, Hai-xia Yu, Xiao-sa Du, Jun Li, Cheng Huang
    Toxicology Letters.2020; 319: 11.     CrossRef
  • The assembly of integrated rat intestinal‐hepatocyte cultures
    Anjaney Kothari, Padmavathy Rajagopalan
    Bioengineering & Translational Medicine.2020;[Epub]     CrossRef
  • Nonpharmacologic Management of Hepatic Encephalopathy
    Vanessa Weir, K. Rajender Reddy
    Clinics in Liver Disease.2020; 24(2): 243.     CrossRef
  • The correlation between intestinal mucosal lesions and hepatic dysfunction in patients without chronic liver disease
    Li-Hao Wu, Mei-Hui Chen, Jie-Yi Cai, Yu Yuan, Li-Quan Wu, Hui-Min Zhou, Lan Li, Kayiu Wan, Xing-Xiang He
    Medicine.2020; 99(7): e18837.     CrossRef
  • Maternal hepatitis B or hepatitis C virus carrier status and long‐term infectious morbidity of the offspring: A population‐based cohort study
    Naim Abu Freha, Tamar Wainstock, Liat Poupko, Avni Yonat Shemer, Ruslan Sergienko, Eyal Sheiner
    Journal of Viral Hepatitis.2020; 27(8): 794.     CrossRef
  • The role of oligosaccharides and polysaccharides of xylan and mannan in gut health of monogastric animals
    Utsav P. Tiwari, Stephen A. Fleming, Muhammed S. Abdul Rasheed, R. Jha, Ryan N. Dilger
    Journal of Nutritional Science.2020;[Epub]     CrossRef
  • Nonalcoholic fatty liver disease and portal hypertension
    Marvin Ryou, Nicholas Stylopoulos, Gyorgy Baffy
    Exploration of Medicine.2020; 1(3): 149.     CrossRef
  • Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer
    Anna Zagórska, Paqui G Través, Lidia Jiménez-García, Jenna D Strickland, Joanne Oh, Francisco J Tapia, Rafael Mayoral, Patrick Burrola, Bryan L Copple, Greg Lemke
    Life Science Alliance.2020; 3(8): e202000694.     CrossRef
  • Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis
    Yong-Tao Li, Jian-Rong Huang, Mei-Lian Peng
    BioMed Research International.2020; 2020: 1.     CrossRef
  • The hepatic microenvironment and regulatory T cells
    Daniel Osei-Bordom, Amber G. Bozward, Ye Htun Oo
    Cellular Immunology.2020; 357: 104195.     CrossRef
  • Three-tissue microphysiological system for studying inflammatory responses in gut-liver Axis
    Joong-won Jeon, Nakwon Choi, Seung Hwan Lee, Jong Hwan Sung
    Biomedical Microdevices.2020;[Epub]     CrossRef
  • Alcohol decreases intestinal ratio of Lactobacillus to Enterobacteriaceae and induces hepatic immune tolerance in a murine model of DSS-colitis
    Paulius V. Kuprys, Abigail R. Cannon, Jennifer Shieh, Noama Iftekhar, Sun K. Park, Joshua M. Eberhardt, Xianzhong Ding, Mashkoor A. Choudhry
    Gut Microbes.2020; 12(1): 1838236.     CrossRef
  • Determinación de la microbiota intestinal en pacientes cirróticos de población mestizo-mexicana
    C. Pérez-Monter, I. Escalona-Nandez, A. Estanes-Hernández, L.G. Noriega-López, A. Torre-Delgadillo
    Revista de Gastroenterología de México.2019; 84(1): 26.     CrossRef
  • Intestinal microbiota assessment in cirrhotic patients from a Mexican mestizo population
    C. Pérez-Monter, I. Escalona-Nandez, A. Estanes-Hernández, L.G. Noriega-López, A. Torre-Delgadillo
    Revista de Gastroenterología de México (English Edition).2019; 84(1): 26.     CrossRef
  • Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
    Amandeep K. Dhillon, Martin Kummen, Marius Trøseid, Sissel Åkra, Evaggelia Liaskou, Bjørn Moum, Mette Vesterhus, Tom H. Karlsen, Ingebjørg Seljeflot, Johannes R. Hov, Gabriele Missale
    Liver International.2019; 39(2): 371.     CrossRef
  • Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease
    Zijian Sun, Binxia Chang, Ang Huang, Shuli Hao, Miaomiao Gao, Ying Sun, Ming Shi, Lei Jin, Wei Zhang, Jun Zhao, Guangju Teng, Lin Han, Hui Tian, Qingsheng Liang, Ji-Yuan Zhang, Zhengsheng Zou
    Journal of Cellular and Molecular Medicine.2019; 23(2): 887.     CrossRef
  • Role of the Gut-Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship
    Naoko Ohtani, Norifumi Kawada
    Hepatology Communications.2019; 3(4): 456.     CrossRef
  • Mechanism of neoagarotetraose protects against intense exercise-induced liver injury based on molecular ecological network analysis
    Xin Chen, Jiahong Yu, Changhu Xue, Yuming Wang, Qingjuan Tang, Xiangzhao Mao
    Bioscience, Biotechnology, and Biochemistry.2019; 83(7): 1227.     CrossRef
  • Bacillus amyloliquefaciens SC06 Protects Mice Against High-Fat Diet-Induced Obesity and Liver Injury via Regulating Host Metabolism and Gut Microbiota
    Yang Wang, Yanping Wu, Baikui Wang, Han Xu, Xiaoqiang Mei, Xiaogang Xu, Xiaoping Zhang, Jiajia Ni, Weifen Li
    Frontiers in Microbiology.2019;[Epub]     CrossRef
  • Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
    Hiroshi Fukui
    Diseases.2019; 7(4): 58.     CrossRef
  • Non-viral liver diseases: pathogenetic approaches to therapy
    M. A. Osadchuk, E. D. Mironova
    Medical alphabet.2019; 3(20): 30.     CrossRef
  • Bowel Wall Thickness, Elasticity, Intestinal Permeability, and Inflammatory Cytokines in Patients with Cirrhosis and Ascites
    Sang Hyuk Lee, Heon-Ju Kwon, Nam Hee Kim, Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Eun Hye Park, Byung Ik Kim
    The Korean Journal of Medicine.2019; 94(6): 511.     CrossRef
  • Role of bile acids in the diagnosis and progression of liver cirrhosis: A prospective observational study
    Ning Liu, Jiao Feng, Yang Lv, Qing Liu, Jingfan Deng, Yujing Xia, Chuanyong Guo, Yingqun Zhou
    Experimental and Therapeutic Medicine.2019;[Epub]     CrossRef
  • Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg
    Juan P. Arab, Rosa M. Martin-Mateos, Vijay H. Shah
    Hepatology International.2018; 12(S1): 24.     CrossRef
  • Elevated systemic zonula occludens 1 is positively correlated with inflammation in cirrhosis
    Ashwini Karthikeyan, Pazhanivel Mohan, Palanivel Chinnakali, Balasubramaniyan Vairappan
    Clinica Chimica Acta.2018; 480: 193.     CrossRef
  • Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial
    Hyung Joon Yim, Sang Jun Suh, Young Kul Jung, Sun Young Yim, Yeon Seok Seo, Yu Rim Lee, Soo Young Park, Jae Young Jang, Young Seok Kim, Hong Soo Kim, Byung Ik Kim, Soon Ho Um
    American Journal of Gastroenterology.2018; 113(8): 1167.     CrossRef
  • Chronic moderate alcohol consumption relieves high-fat high-cholesterol diet-induced liver fibrosis in a rat model
    Furong Sun, Zhenjie Zhuang, Dai Zhang, Yushuai Chen, Shu Liu, Nan Gao, Junping Shi, Bingyuan Wang
    Clinical and Experimental Pharmacology and Physiology.2018; 45(10): 1046.     CrossRef
  • IgG Antibodies to GlcNAcβand Asialo-GM2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment
    Eugeniy Smorodin, Boris Sergeyev, Oleg Kurtenkov, Tatiana Kuznetsova, Julia Geller
    Disease Markers.2018; 2018: 1.     CrossRef
  • Correlation of liver function with intestinal flora, vitamin deficiency and IL-17A in patients with liver cirrhosis
    Haijuan Mou, Fengying Yang, Jianqin Zhou, Cuixia Bao
    Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
  • Alcohol Modulation of the Postburn Hepatic Response
    Michael M. Chen, Stewart R. Carter, Brenda J. Curtis, Eileen B. O’Halloran, Richard L. Gamelli, Elizabeth J. Kovacs
    Journal of Burn Care & Research.2017; 38(1): e144.     CrossRef
  • Molecular mechanisms of hepatopulmonary syndrome
    I.Ya. Krynytska Krynytska, M.I. Marushchak, I. M. Klishch, I.V. Birchenko
    Fiziolohichnyĭ zhurnal.2017; 63(3): 90.     CrossRef
  • Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
    Sukhpreet Singh, Natalia A Osna, Kusum K Kharbanda
    World Journal of Gastroenterology.2017; 23(36): 6549.     CrossRef
  • Dietary capsaicin and antibiotics act synergistically to reduce non-alcoholic fatty liver disease induced by high fat diet in mice
    Jingjuan Hu, Haihua Luo, Yong Jiang, Peng Chen
    Oncotarget.2017; 8(24): 38161.     CrossRef
  • Pathogenesis of nonalcoholic steatohepatitis
    Wensheng Liu, Robert D. Baker, Tavleen Bhatia, Lixin Zhu, Susan S. Baker
    Cellular and Molecular Life Sciences.2016; 73(10): 1969.     CrossRef
  • Pathogenesis of Alcoholic Liver Disease
    Winston Dunn, Vijay H. Shah
    Clinics in Liver Disease.2016; 20(3): 445.     CrossRef
  • Alcohol and lung injury and immunity
    Samantha M. Yeligar, Michael M. Chen, Elizabeth J. Kovacs, Joseph H. Sisson, Ellen L. Burnham, Lou Ann S. Brown
    Alcohol.2016; 55: 51.     CrossRef
  • New treatment options for alcoholic hepatitis
    Saggere Muralikrishna Shasthry, Shiv Kumar Sarin
    World Journal of Gastroenterology.2016; 22(15): 3892.     CrossRef
  • Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in rats
    Jin-Hang Gao, Shi-Lei Wen, Huan Tong, Chun-Hui Wang, Wen-Juan Yang, Shi-Hang Tang, Zhao-Ping Yan, Yang Tai, Cheng Ye, Rui Liu, Zhi-Yin Huang, Ying-Mei Tang, Jin-Hui Yang, Cheng-Wei Tang
    American Journal of Physiology-Gastrointestinal and Liver Physiology.2016; 310(11): G962.     CrossRef
  • Changes of Intestinal Functions in Liver Cirrhosis
    Hiroshi Fukui, Reiner Wiest
    Inflammatory Intestinal Diseases.2016; 1(1): 24.     CrossRef
  • IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats
    Tian-Yu Zhao, Li-Ping Su, Chun-Ye Ma, Xiao-Han Zhai, Zhi-Jun Duan, Ying Zhu, Gang Zhao, Chun-Yan Li, Li-Xia Wang, Dong Yang
    BMC Gastroenterology.2015;[Epub]     CrossRef
  • Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis
    Sang Hak Han, Ki Tae Suk, Dong Joon Kim, Moon Young Kim, Soon Koo Baik, Young Don Kim, Gab Jin Cheon, Dae Hee Choi, Young Lim Ham, Dong Hoon Shin, Eun Ji Kim
    European Journal of Gastroenterology & Hepatology.2015; 27(11): 1300.     CrossRef
  • Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001)
    Mitsuo Shimada, Yuji Morine, Hiroaki Nagano, Etsuro Hatano, Takashi Kaiho, Masaru Miyazaki, Toru Kono, Toshiya Kamiyama, Satoshi Morita, Junichi Sakamoto, Mitsuo Kusano, Shigetoyo Saji, Takashi Kanematsu, Masaki Kitajima
    International Journal of Clinical Oncology.2015; 20(1): 95.     CrossRef
  • The relevance of intestinal dysbiosis in liver transplant candidates
    M. Grąt, W. Hołówko, K.M. Wronka, K. Grąt, Z. Lewandowski, I. Kosińska, M. Krasnodębski, M. Wasilewicz, M. Gałęcka, P. Szachta, H. Zborowska, W. Patkowski, M. Krawczyk
    Transplant Infectious Disease.2015; 17(2): 174.     CrossRef
  • Gut Microbiota and Host Reaction in Liver Diseases
    Hiroshi Fukui
    Microorganisms.2015; 3(4): 759.     CrossRef
  • Hepatic Hemangioma in Celiac Patients: Data from a Large Consecutive Series
    Sara Massironi, Federica Branchi, Roberta Elisa Rossi, Mirella Fraquelli, Luca Elli, Maria Teresa Bardella, Federica Cavalcoli, Dario Conte
    Gastroenterology Research and Practice.2015; 2015: 1.     CrossRef
  • Effects of Lycium barbarum on bacterial translocation in thioacetamide-induced liver injury in rats
    Y Bilgic, MMM Harputluoglu, O Kutlu, U Demirel, M Gul, B Otlu, I Temel, S Gursoy, R Dertli, EB Selcuk, I Yilmaz, T Kilis
    European Journal of Inflammation.2015; 13(3): 154.     CrossRef
  • Gut microbiota and liver diseases
    Masami Minemura
    World Journal of Gastroenterology.2015; 21(6): 1691.     CrossRef
  • Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis
    Melisa Dirchwolf
    World Journal of Hepatology.2015; 7(16): 1974.     CrossRef
  • Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
    Hiroshi Fukui
    World Journal of Hepatology.2015; 7(3): 425.     CrossRef
  • Pathophysiology of Portal Hypertension
    Yasuko Iwakiri
    Clinics in Liver Disease.2014; 18(2): 281.     CrossRef
  • Pre-eclampsia renamed and reframed: Intra-abdominal hypertension in pregnancy
    Diane J. Sawchuck, Bernd K. Wittmann
    Medical Hypotheses.2014; 83(5): 619.     CrossRef
  • The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease
    Silvia Ferolla, Geyza Armiliato, Cláudia Couto, Teresa Ferrari
    Nutrients.2014; 6(12): 5583.     CrossRef
  • Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
    William Peverill, Lawrie Powell, Richard Skoien
    International Journal of Molecular Sciences.2014; 15(5): 8591.     CrossRef
  • Effects of Korean Red Ginseng (Panax ginseng), urushiol (Rhus vernicifera Stokes), and probiotics (Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) on the gut–liver axis of alcoholic liver disease
    Chang Seok Bang, So Hyung Hong, Ki Tae Suk, Jin Bong Kim, Sang Hak Han, Hotaik Sung, Eun Ji Kim, Myoung Jo Kim, Moon Young Kim, Soon Koo Baik, Dong Joon Kim
    Journal of Ginseng Research.2014; 38(3): 167.     CrossRef
  • Role of a Bacillus subtilis Direct-Fed Microbial on Digesta Viscosity, Bacterial Translocation, and Bone Mineralization in Turkey Poults Fed with a Rye-Based Diet
    Juan D. Latorre, Xochitl Hernandez-Velasco, Michael H. Kogut, Jose L. Vicente, Ross Wolfenden, Amanda Wolfenden, Billy M. Hargis, Vivek A. Kuttappan, Guillermo Tellez
    Frontiers in Veterinary Science.2014;[Epub]     CrossRef
  • n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis
    Angela Provenzano, Stefano Milani, Francesco Vizzutti, Wanda Delogu, Nadia Navari, Erica Novo, Marina Maggiora, Valter Maurino, Giacomo Laffi, Maurizio Parola, Fabio Marra
    Liver International.2014; 34(6): 918.     CrossRef
  • Alcoholic liver disease: Treatment
    Ki Tae Suk
    World Journal of Gastroenterology.2014; 20(36): 12934.     CrossRef
  • An alteration of the gut-liver axis drives pulmonary inflammation after intoxication and burn injury in mice
    Michael M. Chen, Anita Zahs, Mary M. Brown, Luis Ramirez, Jerrold R. Turner, Mashkoor A. Choudhry, Elizabeth J. Kovacs
    American Journal of Physiology-Gastrointestinal and Liver Physiology.2014; 307(7): G711.     CrossRef
  • Toll-Like Receptor 2 Activation by β2→1-Fructans Protects Barrier Function of T84 Human Intestinal Epithelial Cells in a Chain Length–Dependent Manner
    Leonie M. Vogt, Diederick Meyer, Gerdie Pullens, Marijke M. Faas, Koen Venema, Uttara Ramasamy, Henk A. Schols, Paul de Vos
    The Journal of Nutrition.2014; 144(7): 1002.     CrossRef
  • Reply to: “Uncovering the molecular events associated with increased intestinal permeability in liver cirrhosis: The pivotal role of enterocyte tight junctions and future perspectives”
    Johannie du Plessis, Schalk W. van der Merwe
    Journal of Hepatology.2013; 59(5): 1146.     CrossRef
  • The gut microbiota and the liver: implications for clinical practice
    Eamonn M Quigley, Howard P Monsour
    Expert Review of Gastroenterology & Hepatology.2013; 7(8): 723.     CrossRef
  • Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers
    Bjørn S. Madsen, Troels Havelund, Aleksander Krag
    Advances in Therapy.2013; 30(7): 659.     CrossRef
  • 17,189 View
  • 219 Download
  • Crossref